There is a paucity of head-to-head comparisons of the efficacy and harms of pharmacological treatments for systemic sclerosis-related interstitial lung disease (SSc-ILD).
Efficacy, Safety, and Tolerability of Treatments for Systemic Sclerosis-Related Interstitial Lung Disease: A Systematic Review and Network Meta-Analysis / Erre, Gian Luca; Sebastiani, Marco; Fenu, Maria Antonietta; Zinellu, Angelo; Floris, Alberto; Cavagna, Lorenzo; Renzoni, Elisabetta; Manfredi, Andreina; Passiu, Giuseppe; Woodman, Richard John; Mangoni, Arduino Aleksander. - In: JOURNAL OF CLINICAL MEDICINE. - ISSN 2077-0383. - 9:8(2020), p. 2560. [10.3390/jcm9082560]
Efficacy, Safety, and Tolerability of Treatments for Systemic Sclerosis-Related Interstitial Lung Disease: A Systematic Review and Network Meta-Analysis
Erre, Gian Luca
;Fenu, Maria Antonietta;Zinellu, Angelo;Passiu, Giuseppe;Mangoni, Arduino Aleksander
2020-01-01
Abstract
There is a paucity of head-to-head comparisons of the efficacy and harms of pharmacological treatments for systemic sclerosis-related interstitial lung disease (SSc-ILD).I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
